Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04184271 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetics of Advantage Arrest
A Phase 2 study, sponsored by Advantage Silver Dental Arrest.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT04184271 is a Phase 2 study that has completed, run by Advantage Silver Dental Arrest. The registered enrollment target is 16 participants.
The verdict
NCT04184271, a Phase 2 study, has completed, sponsored by Advantage Silver Dental Arrest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study aim is to characterize the kinetics of silver and fluoride after topical application of silver diamine fluoride.
Interventions
- DRUG 38% silver diamine fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04184271
The ClinicalTrials.gov registry entry for NCT04184271 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advantage Silver Dental Arrest, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 38% silver diamine fluoride is the first listed.
NCT04184271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04184271 about?
NCT04184271 is a clinical study titled "Pharmacokinetics of Advantage Arrest". The study aim is to characterize the kinetics of silver and fluoride after topical application of silver diamine fluoride.
What is the current status of trial NCT04184271?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2017-08-01. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT04184271?
The interventions under investigation include: 38% silver diamine fluoride (DRUG).
Who is sponsoring clinical trial NCT04184271?
This trial is sponsored by Advantage Silver Dental Arrest, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.